Clinipace
John Scott joined Clinipace in March 2020 as chief information officer, bringing broad biotechnology and pharmaceutical industry technology and process management experience. He manages the technology services across clinical systems, business systems, and all supporting technology services. Prior to Clinipace, Scott held senior leadership roles at private and public companies, including UnitedHealth Group’s OptumRx, Amgen, and Bayer. Since 2016 he has been engaged with private equity firms focused on the life sciences industry.
This person is not in any offices
Clinipace
Clinipace is a global, full-service contract research organization (CRO). Their personalized services and solutions, local regulatory expertise and therapeutic leadership are designed to face the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology.